Third Party Funds Group - Sub project
Acronym: GRK 2950 P4
Start date : 01.06.2024
End date : 31.05.2029
The vision is to use tiny Magnetic particles as carriers for anti cancer drugs. By magnetic fields we can steer these particles and guide them through the human vessel system towards a carcinoma. By that we want to contribute to the development of a new cancer therapy, with less unwanted side effects.
In our suproject we are studying new techniques for steering SPIONs (Super Paramagnetic Ion Oxides Nanoparticles) towards a target region by using specially shaped magnetic gradient fields.